drug

leuprolide

1 story · latest Aug 26, 2026

Status: FDA approved Jan 1989 · NDA019732, NDA019943, NDA020011, NDA020263, NDA020517, NDA020708, NDA021343, NDA021379, NDA021488, NDA021731, NDA205054, NDA211488, NDA213150, NDA213225, NDA219745
Brands: Camcevi, Camcevi Etm, Camcevi Kit, Eligard, Eligard Kit, Fensolvi, Fensolvi Kit, Leup, Leuprolide Acetate Depot, Leuprolide Acetate For Depot Suspension, Lupron, Lupron Depot, Lupron Depot-Ped, Lupron Depot-Ped Kit, Lutrate Depot, Vabrinty, Viadur, Vobrig
Codes: A 43818, A43818, Abbott 43818, TAP 144, TAP144
Trials: 3 registered trials in coverage

Relationships

Developed by AbbVie

Developed by Sun Pharmaceutical Industries

Developed by Cipla

Also known as

leuprolide acetate, leuprolide mesylate

Timeline

FDA approves Sun Pharma's Vobrig, a leuprolide acetate injection

Aug 26Regulatory decisionleuprolide Sun Pharmaceutical Industries

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.